Search for Abstracts Find by Title, Author or Description Year Abstracts - 2025 - 2024 - 2023 - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-NuclearMedicine-InterventionalRadiology-Imaging Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology O OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first [C29] Jha - Diagnostic Performance of PET or PET/CT Utilizing 18F-DOPA, 68Ga-DOTATATE, 18F-FDG, 18F-FDA, and CT and MRI the Detection of VHL-related Pheochromocytoma Published in 2022 Listed under Clinical Download [C29] D'Souza - Initial Outcomes of Integrating Yttrium-90 Radioembolization with Capecitabine-Temozolomide for Grade 3 Liver-Dominant Metastatic Neuroendocrine Tumors Published in 2024 Listed under Clinical Download [C28] Zhou - Liver-directed therapy for metastatic neuroendocrine carcinoma and grade 3 well-differentiated neuroendocrine tumors Published in 2024 Listed under Clinical Download [C28] Poster - Zhou - Liver - directed therapy for metastatic neuroendocrine carcinoma and grade 3 well - differentiated neuroendocrine tumors Published in 2024 Listed under Clinical, Poster Download [C28] Jha - Diagnostic Performance of PET or PET/CT Utilizing 18F-DOPA, 68Ga-DOTATATE, 18F-FDG, 18F-FDA, and CT and MRI in the Detection of MEN2A-relatedpheochromocytoma Published in 2022 Listed under Clinical Download [C28] Chauhan - ETCTN 10450: A phase I trial of peposertib and lutetium 177 DOTATATE in well-differentiated somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Published in 2023 Listed under Clinical Download [C27] Poster - Fidelman - A Pilot Study of Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Grade 2/3 Well - Differentiated Neuroendocrine Tumors Published in 2024 Listed under Clinical, Poster Download [C27] Jha - Performance of 68Ga-DOTATATE PET/CT, 18F-FDG PET/CT, CT, and MRI Spine in the Detection of Spinal Bone Metastases in Metastatic Pheochromocytoma/Paraganglioma Published in 2022 Listed under Clinical Download [C27] Fidelman - A Pilot Study of Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Metastases Published in 2024 Listed under Clinical Download [C27] Chauhan - ETCTN 10388: A first in human Phase I Trial of Triapine and Lutetium Lu 177 DOTATATE in Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Published in 2023 Listed under Clinical Download [C26] Meredith - Incidence and Characterization of Carcinoid Crises post Embolization of Neuroendocrine Tumor Liver Metastases Published in 2024 Listed under Clinical Download [C26] Mallak - Pre-therapy Functional Imaging with MIBG and DOTATATE to Guide Radiopharmaceutical Therapy for Pheochromocytoma and Paraganglioma: A Single Institution Experience Published in 2022 Listed under Clinical Download [C26] Fidelman - A Pilot Study of Pembrolizumab and Embolization or 90Y Radioembolization for Patients with Metastatic Well- Differentiated Neuroendocrine Tumors Published in 2023 Listed under Clinical Download [C25] Poster - O'Leary - Associations between patterns of neuroendocrine liver metastatic burden and outcomes after embolization, CapTem and PRRT Published in 2024 Listed under Clinical, Poster Download [C25] O'Leary - Does Liver Tumor Morphology Predict Outcomes after LDT, PRRT or CapTem? Published in 2024 Listed under Clinical Download [C25] Heying - Evaluation of 68Ga-DOTATATE PET After Two Cycles of Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET) Published in 2022 Listed under Clinical Download [C25] Fidelman - A Pilot Study of Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well- Differentiated Neuroendocrine Tumors Published in 2023 Listed under Clinical Download [C24] Nunez - 68Ga-DOTATATE/18F-FDG dual PET: Utility of the NETPET score in management of G2-3 WD NENs Published in 2023 Listed under Clinical Download [C24] Mittra - MIBG and DOTATATE Therapy for Pheochromocytoma and Paraganglioma: A Single Institution Experience Published in 2022 Listed under Clinical Download [C24] Barnett - Evaluating Time to Treatment Start for Patients Receiving Peptide Receptor Radioligand Therapy Published in 2024 Listed under Clinical Download [C23] Poster - Porfido - Neuroendocrine tumor (NET) progression of disease during or within one year after completion of therapy with 177Lu - DOTATATE Published in 2024 Listed under Clinical, Poster Download [C23] Porfido - Neuroendocrine tumor (NET) progression of disease during or within one year after completion of therapy with 177Lu-DOTATATE Published in 2024 Listed under Clinical Download [C23] Lin - Phase 1/2 study of Lu-177-DOTATATE in combination with olaparib in metastatic or inoperable GI neuroendocrine tumors - first results Published in 2023 Listed under Clinical Download [C23] Al-Toubah - Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of Dotatate PET Scans Published in 2022 Listed under Clinical Download [C22] Prela - The Role of 68Ga-DOTATATE PET/CT in the Management of Gastrointestinal and Pancreatic Neuroendocrine Tumors Published in 2022 Listed under Clinical Download [C22] Poster - Porfido - Multicenter clinical registry of patients with a neuroendocrine tumor (NET) diagnosis receiving 177Lu - DOTATATE Published in 2024 Listed under Clinical, Poster Download [C22] Porfido - Multicenter clinical registry of patients with a neuroendocrine tumor (NET) diagnosis receiving 177Lu-DOTATATE Published in 2024 Listed under Clinical Download [C22] Lin - Phase 2 Trial of Lu-177-DOTATATE in Metastatic or Inoperable Pheochromocytoma/Paraganglioma: Interim Analysis Results Published in 2023 Listed under Clinical Download [C21] Lin - Ratio of total uptake volume on DOTATATE vs FDG PET as a predictive marker of treatment efficacy of Lu-177- DOTATATE in metastatic pheochromocytoma Published in 2023 Listed under Clinical Download [C21] del Rivero - Effect of Absorbed Dose on Toxicity and Tumor Response of Lu-177-DOTATATE With Olaparib in Gastroenteropancreatic Neuroendocrine Patients: Preliminary Results Published in 2024 Listed under Clinical Download [C21] Coston - Characterizing Bone Metastases in Patients with Well-Differentiated Neuroendocrine Neoplasms Utilizing Ga68-DOTATATE PET Published in 2022 Listed under Clinical Download [C20] Yuan - Yttrium 90 transarterial radioembolization of neuroendocrine liver metastasis Published in 2023 Listed under Clinical Download [C20] Sriwastwa - Imaging, Clinical, and Safety Outcomes in Metastatic Neuroendocrine Tumor Patients Treated with Peptide Receptor Radionuclide Therapy in the Midwestern USA Published in 2024 Listed under Clinical Download [C20] Jimenez - Quality of Life Assessments for Advanced Pheochromocytoma and Paraganglioma Patients that Received High-Specific-Activity I-131 MIBG: Results from a Pivotal Phase 2 Clinical Trial Published in 2022 Listed under Clinical Download [C1] Singh - Progression-Free Survival in Patients with Bronchopulmonary Neuroendocrine Tumors Treated with Lanreotide or Placebo: Adjustment for Crossover Effects in Placebo Arm Published in 2022 Listed under Clinical Download [C1] Poster - Mohamed - NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A PIlot Study Published in 2024 Listed under Clinical, Poster Download [C1] Mohamed - NP-101 in Combination with Nivolumab and Ipilimumab in Metastatic Extra-pulmonary Neuroendocrine Carcinomas (EP-NECs): A Pilot Study Published in 2024 Listed under Clinical Download [C19] Yadav - The Impact of Post-Treatment Imaging in Peptide Receptor Radionuclide Therapy Published in 2023 Listed under Clinical Download [C19] Poster - Mosalem - Safety of Lutetium-177 DOTATATE Treatment in Patients with Advanced Neuroendocrine Tumors and Extensive/Innumerable Bone Metastases Published in 2024 Listed under Clinical, Poster Download [C19] Moselam - Safety of Lutetium-177 DOTATATE Treatment in Patients with Advanced Neuroendocrine Tumors and Extensive/ Innumerable Bone Metastases Published in 2024 Listed under Clinical Download [C18] Soulen - Radiosensitization for TARE: Does Duration of Chemotherapy Affect PFS? Published in 2022 Listed under Clinical Download [C18] Grage - [68Ga] DOTA-TATE (NETSpot) PET/CT Imaging of Pulmonary Neuroendocrine Tumors Published in 2023 Listed under Clinical Download [C18] del Rivero - DNA Damage Repair Mutational Status’s Effect on Lu-177- DOTATATE in Combination with Olaparib in Metastatic SSTR+ GI Neuroendocrine Tumor: Preliminary Results Published in 2024 Listed under Clinical Download [C17] Halperin - ACTION-1 phase Ib/3 trial of RYZ101 in gastroenteropancreatic neuroendocrine tumors progressing after 177Lu somatostatin analogue therapy: Phase 1b safety/efficacy Published in 2024 Listed under Clinical Download [C17] Ana - Argentinian Registry of Gastric Neuroendocrine Tumors: A closer look at Type 1 Published in 2023 Listed under Clinical Download [C16] Strosberg - Targeted Alpha Therapy with 212Pb-DOTAMTATE in subjects with advanced somatostatin receptor-expressing gastroenteropancreatic neuroendocrine tumors Published in 2024 Listed under Clinical Download [C16] Khuong Le - Comparison of Well-differentiated Gastroenteropancreatic Grade 3 Neuroendocrine Tumors (G3NETs): De Novo and In The Setting of Apparent Grade Progression Over Time Published in 2023 Listed under Clinical Download [C15] Shaheen - RECIST for the real world: Impact of Response Evaluation Criteria in Solid Tumors compared to standard radiology reports on physician decisions and patient satisfaction Published in 2024 Listed under Clinical Download [C15] Poster - Shaheen - RECIST for the real world: Impact of Response Evaluation Criteria in Solid Tumors compared to standard radiology reports on p hys ician decisions and patient satisfaction Published in 2024 Listed under Clinical, Poster Download [C15] Delpassand - Effectiveness and Safety of Re-Treatment with 177Lu- DOTATATE in Patients With Progressive NETs in the US: a Retrospective Real-World Study Published in 2022 Listed under Clinical Download [C15] Chauhan - Phase II study of frontline maintenance rucaparib in combination with nivolumab in extensive stage small cell lung cancer Published in 2023 Listed under Clinical Download [C14] Shrestha - Approach Integrating ERCP with Radiofrequency Ablation for Long-term Management for metastatic pancreatic NET to biliary tree as klatskin tumor Published in 2024 Listed under Clinical Download [C14] Schnell - Cabozantinib as salvage therapy for well differentiated grade 3 neuroendocrine tumors (G3 NETs) Published in 2023 Listed under Clinical Download [C13] Poster - Mulla - Patterns of long-term remission or apparent cure in a cohort of patients with grade 3 neuroendocrine neoplasms (NENs) Published in 2024 Listed under Clinical, Poster Download [C13] Mulla - Patterns of long-term remission or apparent cure in a cohort of patients with grade 3 neuroendocrine neoplasms (NENs) Published in 2024 Listed under Clinical Download [C13] Eslinger - Clinical characteristics and molecular profiling of patients with pancreatic mixed acinar-neuroendocrine carcinoma Published in 2023 Listed under Clinical Download [C13] Blanford - Serum Serotonin Compared to Plasma 5-HIAA and Chromogranin A as Biomarkers of Response to Hepatic Artery Bland Embolization Published in 2022 Listed under Clinical Download [C12] Roy - Financial Toxicity and Supportive Care in Neuroendocrine Tumor: A Biobank Study Published in 2022 Listed under Clinical Download [C12] Phillips - Real world use of virtual care for treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) Published in 2023 Listed under Clinical Download [C12] Capdevila - Updated Phase 1 data for the DLL3/CD3 IgG-like T-cell engager BI 764532 in DLL3-positive tumors: focus on extrapulmonary neuroendocrine carcinomas Published in 2024 Listed under Clinical Download [C11] Pattnaik - Survivin and DLL-3 as predictors of survival in low-grade neuroendocrine tumor patients Published in 2024 Listed under Clinical Download [C11] Orenbach - Results from the Phase 1, Randomized, Open-Label, Cross-Over Study to Evaluate Pharmacokinetics of Three Escalating Doses of Oral Octreotide Capsules Published in 2022 Listed under Clinical Download [C11] McGlothlin - Transformation of Low-Intermediate Grade Neuroendocrine Tumors into High Grade Morphology Published in 2023 Listed under Clinical Download [C10] Strosberg - RZ358 (Ersodetug) as a Novel Therapy for Hypoglycemia due to Tumor Hyperinsulinism: Outcomes from an Expanded Access Program for Compassionate Use Published in 2024 Listed under Clinical Download [C10] Pelle - ACTH-secreting Pancreatic Neuroendocrine Neoplasms: A Case-Series Published in 2022 Listed under Clinical Download [C10] Gambardella - An ongoing phase I trial of the DLL3/CD3 IgG-like T-cell engager, BI 764532, in patients with DLL3-positive extrapulmonary neuroendocrine carcinomas Published in 2023 Listed under Clinical Download C9 - Relationship Between Metabolic Toxicity and Efficacy of Everolimus in Patients with Neuroendocrine Tumors (NETs): A Pooled Analysis From the Randomized, Phase 3 RADIANT-3 and RADIANT-4 Trials Published in 2018 Listed under Clinical, Poster Download Abstract ID: 24 Nicola Fazio, Carlo Carnaghi, Juan W Valle, Fabian Herbst, Antonia Ridolfi, Jonathan Strosberg, Matthew Helmut Kulke, Marianne Pavel, James C Yao pdf Download Poster (3.31 MB) C9 - PD-1 Blockade in Advanced Adrenocortical Carcinoma Published in 2019 Listed under Clinical Download Nitya Raj; Youyun Zheng; Virginia Kelly; Seth Katz; Joanne Chou; Richard Do; Marinela Capanu; Dmitriy Zamarin; Leonard Saltz; Charlotte Ariyan; Brian Untch; Eileen O’Reilly; Anuradha Gopalan; Michael Berger; Elly Olino; Neil Segal; Diane Reidy Abstract ID: 118 C8 - Tumor Growth and Regression Rate Constants from the CLARINET Study as Surrogate Endpoints for Progression-Free Survival: A Novel Assessment Approach in Cancer Therapy Published in 2018 Listed under Clinical, Poster Download Abstract ID: 93 Clarisse Dromain, Arturo Loaiza-Bonilla, Thomas Beveridge, Beloo Mirakhur, Julia Wilkerson, Tito Fojo pdf Download Poster (9.18 MB) C8 - Analysis of Factors Related to Gallstones in Patients with Neuroendocrine Tumors Treated with Long-Acting Somatostatin Analogues Published in 2019 Listed under Clinical Download Zhirong Qi; Xudong Qiu; Yuanliang Li; Dou Dou; Jie Luo; Fei Su; Huangying Tan Abstract ID: 97 C7 - Real-world Analysis of Long-Term Treatment Patterns and Clinical Outcomes among Patients with Advanced Neuroendocrine Tumors of Lung Origin: A Multicenter Study Published in 2018 Listed under Clinical Download Abstract ID: 27 Arvind Dasari, Emily K. Bergsland, Al B. Benson, Beilei Cai, Lynn Huynh, Todor Totev, Jesse Shea, Mei Sheng Duh, Maureen P. Neary, Matthew H. Kulke C7 - Outcomes after Cessation of Therapy with Alkylating Agents (AA) For Pancreatic Neuroendocrine Tumors (PanNETs) Published in 2019 Listed under Clinical Download Y. Linda Wu; Diane Reidy; Agata Bielska; Virginia Kelly; Nitya Raj Abstract ID: 92 C64 - Clinicopathological Characteristics and Risk Factors for Recurrence of Well Differentiated Pancreatic Neuroendocrine Tumors After Radical Surgery Published in 2018 Listed under Clinical, Poster Download Abstract ID: 100 Pan Zhang, Yuan-liang Li, Xu-dong Qiu, Huang-ying Tan pdf Download Poster (558 KB) C63 - Role of Plasma Pancreastatin in Predicting Prognosis Following R0/R1 Surgical Cytoreduction in Small Bowel Neuroendocrine Tumors Published in 2018 Listed under Clinical, Poster Download Abstract ID: 65 Eugene A. Woltering, Brianne A. Voros, Ramcharan Thiagarajan, David T. Beyer, Robert A. Ramirez, Gregg Mamikunian, J. Philip Boudreaux pdf Download Poster (885 KB) C62 - Plasma Pancreastatin Levels Predict the Outcome of Surgical Cytoreduction in Neuroendocrine Tumors of the Small Bowel Published in 2018 Listed under Clinical, Poster Download Abstract ID: 69 Eugene A. Woltering, Brianne A. Voros, Ramcharan Thiagarajan, David T. Beyer, Robert A. Ramirez, Gregg Mamikunian, J. Philip Boudreaux pdf Download Poster (854 KB) C61 - Clinical Utility of a Molecular Cancer Classifier for Primary Site Identification in Neuroendocrine Tumors Published in 2018 Listed under Clinical, Poster Download Abstract ID: 111 Brianne A. Voros, Cody Gulizo, J. Philip Boudreaux, Ramcharan Thiagarajan, Robert A. Ramirez, Eugene A. Woltering pdf Download Poster (986 KB) C60 - Primary Neuroendocrine Neoplasms of the Kidney, A Distinct Entity but Classifiable-Like the Gastroenteropancreatic Neuroendocrine Neoplasms Published in 2019 Listed under Clinical Download Manik Amin; Deyali Chatterjee Abstract ID: 168 C60 - Merkel Cell Carcinoma: Clinical Outcome and Prognostic Factors in 351 Patients Published in 2018 Listed under Clinical Download Abstract ID: 40 Linde van Veenendaal, Alexander van Akkooi, Cees Verhoef, Dirk Jan Grünhagen, Martin Klop, Gerlof Valk, Margot Tesselaar C6 - Randomized Phase II Trial of Pazopanib versus Placebo in Patients (Pts) with Progressive Carcinoid Tumors (CARC) (Alliance A021202) Published in 2019 Listed under Clinical Download Emily Bergsland; Michelle Mahoney; Tim Asmis; Nathan Hall; Priya Kumthekar; Michael Maitland; Donna Neidzwiecki; Andrew Nixon; Eileen O’Reilly; Lawrence Schwartz; Jeff Sloan; Jonathan Strosberg; Jeff Meyerhardt Abstract ID: 85 C6 - A Pilot Study of the Cyclin Dependent Kinases 4, 6 Inhibitor Ribociclib in Patients with Foregut Neuroendocrine Tumors Published in 2018 Listed under Clinical, Poster Download Abstract ID: 38 Arvind Dasari, Daniel Halperin, Tapia Coya, Isabel Zorrilla, Funda Meric-Bernstam, James Yao pdf Download Poster (505 KB) C59 - Presacral Neuroendocrine Tumors Associated with the Currarino Syndrome Published in 2019 Listed under Clinical Download Aaron Scott; Jonathon Tessmann; Terry Braun; Bart Brown; Patrick Breheny; Benjamin Darbro; Andrew Bellizzi; Joseph Dillon; Thomas O'Dorisio; Alice Alderson; Bonita Bennett; John Bernat; David Metz; James Howe Abstract ID: 167 C59 - Grade Switch and Survival in a Cohort of 95 Resected Pancreatic Neuroendocrine Neoplasms (PanNEN) Published in 2018 Listed under Clinical, Poster Download Abstract ID: 105 Nikolaos Trikalinos, Chet Hammill, Gregory Williams, William Hawkins, Deyali Chatterjee pdf Download Poster (231 KB) C58 – Chronic use of Long-acting Somatostatin Analogues (SSAs) and Exocrine Pancreatic Insufficiency (EPI) in patients with Gastroenteropancreatic neuroendocrine tumors (GEP-NETs): An Under-recognized Adverse Effect Published in 2017 Listed under Clinical, Poster Download Saif pdf Download Poster (1.49 MB) C58 - The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors Published in 2018 Listed under Clinical, Poster Download Abstract ID: 6 Aaron Scott, Daniel Pelletier, Jessica Maxwell, Scott Sherman, Guiying Li, Joseph Dillon, Thomas O’Dorisio, Andrew Bellizz, James Howe pdf Download Poster (6.05 MB) C58 - Management of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors: Limitations to Apply Guidelines into Real Life Published in 2019 Listed under Clinical Download Valentina Andreasi; Stefano Partelli; Michele Mazza; Francesca Muffatti; Stefano Crippa; Domenico Tamburrino; Massimo Falconi Abstract ID: 159 C57 – Assessment of Disease Aggression in Cystic Pancreatic NET: a CT and Pathology Correlation Study Published in 2017 Listed under Clinical Download Yano Abstract ID: 202 C57 - Metastatic Potential of Small Pancreatic Neuroendocrine Tumors: Not as Innocent as They Seem Published in 2019 Listed under Clinical Download Eduardo Vega; Onur Kutlu; Omid Salehi; Daria James; Olga Kozyreva; Jennifer Chan; Claudius Conrad Abstract ID: 155 C57 - Effective Cytoreduction Can Be Achieved in Patients with Numerous Neuroendocrine Tumor Liver Metastases Published in 2018 Listed under Clinical Download Abstract ID: 4 Aaron Scott, Patrick Breheny, Kendall Keck, Andrew Bellizzi, Joseph Dillon, Thomas O’Dorisio, James Howe C56 – Neuroendocrine Proliferations in Inflammatory Bowel Disease Published in 2017 Listed under Clinical, Poster Download Wong Abstract ID: 306 pdf Download Poster (29.70 MB) C56 - Functional Genomics of Pancreatic Neuroendocrine Tumor Malignancy Published in 2018 Listed under Clinical, Poster Download Abstract ID: 70 Brenna Rheinheimer, Ronald Heimark, Tun Jie pdf Download Poster (6.29 MB) C56 - Association between Preoperative Vasostatin-1 and Pathological Features of Aggressiveness in Localized Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PanNET) Published in 2019 Listed under Clinical Download Valentina Andreasi; Stefano Partelli; Marco Manzoni; Francesca Muffatti; Barbara Colombo; Angelo Corti; Massimo Falconi Abstract ID: 151 C55 – Does Plasma Neurokinin A Predict Survival in Well-Differentiated Neuroendocrine Tumors (NETs) of the Small Bowel? Published in 2017 Listed under Clinical, Poster Download Woltering, MD, FACS Abstract ID: 239 pdf Download Poster (76 KB) C55 - Patterns of Care and Outcomes in Localized, Grad 3, Gastroenteropancreatice Neuroendocrine Neoplasms: A 10-Year Experience in a Tertiary Centre Published in 2019 Listed under Clinical Download Ivan Lyra Gonzalez; Stephanie Moignard; Charles Lim; Osvaldo Espin Garcia; Ozgur Mete; Carol-Anne Moulton; Monika Krzyzanowska; Raymond Jang Abstract ID: 137 C55 - A Retrospective Cohort Study of 1,301 Patients with Pancreatic Neuroendocrine Tumors Identifies Prolonged Survival After Surgical Resection Even in Advanced Stages Published in 2018 Listed under Clinical, Poster Download Abstract ID: 48 Benjamin D. Powers, Ambuj Kumal, Jason B. Fleming, Jonathan Strosberg, Daniel A. Anaya pdf Download Poster (474 KB) C54 – The Immunohistochemical Expression of Islet 1 and PAX8 by Rectal Neuroendocrine Tumors Should be Taken into Account in the Differential Diagnosis of Metastatic Neuroendocrine Tumors of Unknown Primary Origin Published in 2013 Listed under Clinical Download Zhou C54 – Lobectomy with Mediastinal Nodal Dissection vs. Partial Lobectomy in Patients with Bronchial Carcinoid Tumors Published in 2017 Listed under Clinical Download Westin Abstract ID: 235 C54 - Prediction of Survival for Pancreatic Neuroendocrine Tumors: A Systematic Review of Clinical Tools Published in 2019 Listed under Clinical Download George Ho; Kaitlyn Beyfuss; Sten Myrehaug; David Chan; Victoria Zuk; Calvin Law; Alyson Mahar; Julie Hallet Abstract ID: 131 C54 - Examination of Factors Associated with Lymph Node Metastases in Lung Carcinoids Published in 2018 Listed under Clinical, Poster Download Abstract ID: 45 Mythili P. Pathipati, Thomas K. Yohannan, Lu Tian, Jalen A. Benson, Kathleen Hornbacker, Gerald J, Berry, Natalie Lui, Pamela L. Kunz, Sukhmani K. Padda2 pdf Download Poster (724 KB) C53 – The Effects of Peritoneal Carcinomatosis on the Prognosis of Patients with Advanced Midgut Neuroendocrine Tumors Published in 2017 Listed under Clinical Download Wang Abstract ID: 259 C53 – Everolimus Plus Octreotide Long-Acting Repeatable (LAR) for the Treatment of Advanced Neuroendocrine Tumors (NET) Associated with Carcinoid Syndrome: Updated Overall Survival Results from RADIANT-2 Study Published in 2013 Listed under Clinical Download Yao Select the number of documents per page 5 10 15 20 25 30 50 100 «1234…67»
